SANOFI (SAN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
80.5 EUR
-1.91 (-2.32%)
Taking everything into account, SAN scores 5 out of 10 in our fundamental rating. SAN was compared to 53 industry peers in the Pharmaceuticals industry. SAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SAN has a correct valuation and a medium growth rate. SAN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
SAN had positive earnings in the past year.
Each year in the past 5 years SAN has been profitable.
Each year in the past 5 years SAN had a positive operating cash flow.
1.2 Ratios
SAN has a Return On Assets of 10.63%. This is in the better half of the industry: SAN outperforms 75.47% of its industry peers.
SAN's Return On Equity of 18.84% is fine compared to the rest of the industry. SAN outperforms 64.15% of its industry peers.
SAN's Return On Invested Capital of 13.40% is fine compared to the rest of the industry. SAN outperforms 66.04% of its industry peers.
SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 14.02%.
The last Return On Invested Capital (13.40%) for SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
SAN has a Profit Margin of 20.63%. This is in the better half of the industry: SAN outperforms 77.36% of its industry peers.
SAN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 23.61%, SAN is in line with its industry, outperforming 56.60% of the companies in the same industry.
In the last couple of years the Operating Margin of SAN has grown nicely.
SAN has a Gross Margin (72.29%) which is in line with its industry peers.
SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SAN is creating some value.
Compared to 1 year ago, SAN has about the same amount of shares outstanding.
Compared to 5 years ago, SAN has about the same amount of shares outstanding.
The debt/assets ratio for SAN has been reduced compared to a year ago.
2.2 Solvency
A Debt/Equity ratio of 0.18 indicates that SAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, SAN is in the better half of the industry, outperforming 79.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC1.76
WACC7.62%
2.3 Liquidity
SAN has a Current Ratio of 1.06. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
SAN's Current ratio of 1.06 is on the low side compared to the rest of the industry. SAN is outperformed by 69.81% of its industry peers.
A Quick Ratio of 0.30 indicates that SAN may have some problems paying its short term obligations.
SAN has a worse Quick ratio (0.30) than 88.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.41% on average over the next years.
SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.47% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.59 indicates a reasonable valuation of SAN.
Based on the Price/Earnings ratio, SAN is valued cheaply inside the industry as 86.79% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. SAN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.47, the valuation of SAN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SAN is valued cheaply inside the industry as 84.91% of the companies are valued more expensively.
SAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.59 | ||
| Fwd PE | 9.47 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 71.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)4.47
PEG (5Y)2.08
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
SAN has a Yearly Dividend Yield of 4.73%, which is a nice return.
SAN's Dividend Yield is rather good when compared to the industry average which is at 1.72. SAN pays more dividend than 90.57% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, SAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.73% |
5.2 History
The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
SAN pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPA:SAN (1/13/2026, 7:00:00 PM)
80.5
-1.91 (-2.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap195.53B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target106.44 (32.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.73% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-1.1%
PT rev (3m)-2.94%
EPS NQ rev (1m)-1.79%
EPS NQ rev (3m)-10.16%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.59 | ||
| Fwd PE | 9.47 | ||
| P/S | 2.92 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.67 | ||
| P/tB | 44.48 | ||
| EV/EBITDA | 10.99 |
EPS(TTM)7.6
EY9.44%
EPS(NY)8.5
Fwd EY10.56%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.54
BVpS30.16
TBVpS1.81
PEG (NY)4.47
PEG (5Y)2.08
Graham Number71.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROCE | 16.17% | ||
| ROIC | 13.4% | ||
| ROICexc | 14.75% | ||
| ROICexgc | 65.74% | ||
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% | ||
| FCFM | N/A |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.62%
ROIC/WACC1.76
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SAN.PA FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
What is the valuation of SANOFI based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.59 and the Price/Book (PB) ratio is 2.67.
How financially healthy is SANOFI?
The financial health rating of SANOFI (SAN.PA) is 3 / 10.